These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7717348)

  • 1. Interferon-alpha is effective in the treatment of chronic hepatitis C.
    Worman HJ
    Am J Gastroenterol; 1995 Apr; 90(4):679-80. PubMed ID: 7717348
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to alpha 2B interferon (IFN) treatment in a haemodialysis patient with chronic hepatitis C.
    Barril G; Schez Tomero JA; Garcia Buey L; Motellon JL; Bernis C; Traver JA
    Nephrol Dial Transplant; 1994; 9(9):1354-5. PubMed ID: 7816309
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
    Simon DM; Gordon SC; Kaplan MM; Koff RS; Regenstein F; Everson G; Lee YM; Weiner F; Silverman A; Plasse T; Fedorczyk D; Liao MJ
    Hepatology; 1997 Feb; 25(2):445-8. PubMed ID: 9021962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune hepatitis type 1 revealed during treatment with interferon].
    Tran A; Beusnel C; Montoya ML; Lussiez V; Hébuterne X; Rampal P
    Gastroenterol Clin Biol; 1992; 16(8-9):722-3. PubMed ID: 1426834
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C: clinical aspects, course and therapy].
    Maier KP
    Schweiz Rundsch Med Prax; 1994 Sep; 83(36):1005-7. PubMed ID: 7939055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing patients with hepatitis C.
    Drug Ther Bull; 1993 Aug; 31(16):61-2. PubMed ID: 8375275
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia].
    Denizon N; Beraud JJ; Mourad G; Blanc P; Bureau JP; Navarro M; Lavabre-Bertrand T
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1039-40. PubMed ID: 11845064
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with alpha-interferon in chronic hepatitis.
    Matei I; Tănăsescu C; Voiosu R; Murariu E; Dragomir P; Serbănescu A
    Rom J Intern Med; 1998; 36(3-4):227-37. PubMed ID: 10822519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus.
    Ikeda K; Kumada H; Saitoh S; Suzuki Y; Kobayashi M; Tsubota A; Koida I; Fukuda M; Arase Y; Chayama K; Murashima N; Tango T
    J Hepatol; 1998 May; 28(5):910-1. PubMed ID: 9625329
    [No Abstract]   [Full Text] [Related]  

  • 15. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of repeatedly normal aminotransferase activities in hepatitis C virus-infected patients.
    Zylberberg H; Nalpas B; Brechot C; Berthelot P
    Hepatology; 1998 Apr; 27(4):1169. PubMed ID: 9537462
    [No Abstract]   [Full Text] [Related]  

  • 17. Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management.
    Roffi L; Mels GC; Antonelli G; Bellati G; Panizzuti F; Piperno A; Pozzi M; Ravizza D; Angeli G; Dianzani F
    Hepatology; 1995 Mar; 21(3):645-9. PubMed ID: 7875661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
    Parolin MB; Lacerda MA; Lopes RW
    Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis/HIV Spanish Study Group.
    Soriano V; Bravo R; García-Samaniego J; Castilla J; González J; Castro A; Llibre JM
    AIDS; 1997 Mar; 11(3):400-1. PubMed ID: 9147443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.